롱리드 시퀀싱 시장 규모, 점유율, 성장 분석 : 제공 제품별, 기술별, 워크플로우별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Long Read Sequencing Market Size, Share, Growth Analysis, By Offerings, By Technology, By Workflow, By Application, By Usage, By End Users, By Region - Industry Forecast 2025-2032
상품코드:1630617
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 01월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
롱리드 시퀀싱 세계 시장 규모는 2023년 5억 9,581만 달러로 평가되며, 2024년 7억 7,992만 달러에서 2032년 67억 2,302만 달러로 확대될 것으로 예상되며, 예측 기간(2025-2032년) 동안 CAGR 30.9 % 성장할 것으로 예상됩니다.
유전자 시퀀싱 시장은 유전성 질환의 발생률 증가, 맞춤형 의료의 부상, 3세대 시퀀싱과 같은 기술 발전에 힘입어 성장하고 있으며, COVID-19 팬데믹은 진단 및 의약품 개발에 있어 혁신적인 시퀀싱 기법에 대한 수요를 더욱 가속화시키고 있습니다. 단일 분자 실시간(SMRT) 및 나노포어(Nanopore)와 같은 롱 리드 시퀀싱 기술은 복잡한 유전체 영역을 정확하게 분석하고 기존 방법으로는 놓치기 쉬운 대규모 구조적 이상을 감지할 수 있어 인기를 끌고 있습니다. 이러한 장점은 특히 유전성 질환에 대해 보다 효율적인 진단을 가능하게 합니다. 또한, 의약품 개발 및 동반진단을 위한 첨단 유전체 기술 개발을 위한 제휴에서 볼 수 있듯이, 주요 기업들의 투자 증가는 시장 성장을 촉진할 것으로 예상됩니다.
목차
소개
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장 가정과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porters 분석
주요 시장 인사이트
핵심성공요인
경쟁 정도
주요 투자 기회
시장 생태계
시장 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
기술의 진보
규제 상황
롱리드 시퀀싱 시장 규모 : 제공 제품별
시장 개요
소모품
기기
서비스
롱리드 시퀀싱 시장 규모 : 기술별
시장 개요
나노포어 시퀀싱
단일 분자 실시간 시퀀싱
합성 롱리드 시퀀싱
롱리드 시퀀싱 시장 규모 : 워크플로우별
시장 개요
시퀀싱
샘플 조제
데이터 분석
롱리드 시퀀싱 시장 규모 : 용도별
시장 개요
전장 유전체 배열 해석
타겟 시퀀싱
군유전체학
후생유전학
전장 엑솜 배열 해석
기타 용도
롱리드 시퀀싱 시장 규모 : 이용별
시장 개요
조사
임상
롱리드 시퀀싱 시장 규모 : 최종사용자별
시장 개요
학술조사기관
병원 진료소 진단 실험실
제약·바이오테크놀러지 기업
기타 최종사용자
롱리드 시퀀싱 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5개사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채용한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출 전년비 비교(2022-2024년)
주요 기업 개요
Pacific Biosciences of California, Inc.(PacBio)(United States)
Oxford Nanopore Technologies plc(United Kingdom)
Illumina, Inc.(United States)
BGI Genomics Co., Ltd.(China)
10x Genomics, Inc.(United States)
Agilent Technologies, Inc.(United States)
Thermo Fisher Scientific Inc.(United States)
QIAGEN N.V.(Germany)
Takara Bio Inc.(Japan)
Danaher Corporation(United States)
Novogene Co., Ltd.(China)
New England Biolabs, Inc.(United States)
Element Biosciences, Inc.(United States)
Revvity, Inc.(United States)
Eurofins Scientific SE(Luxembourg)
Bio-Rad Laboratories, Inc.(United States)
PerkinElmer, Inc.(United States)
Roche Holding AG(Switzerland)
Merck KGaA(Germany)
Bio-Techne Corporation(United States)
결론과 추천사항
KSM
영문 목차
영문목차
Global Long Read Sequencing Market size was valued at USD 595.81 million in 2023 and is poised to grow from USD 779.92 million in 2024 to USD 6723.02 million by 2032, growing at a CAGR of 30.9% during the forecast period (2025-2032).
The market for genetic sequencing is being driven by the increasing incidence of genetic disorders, the rise of personalized medicine, and advancements in technologies like third-generation sequencing. The COVID-19 pandemic has further accelerated the demand for innovative sequencing methods in diagnostics and drug development. Long read sequencing techniques, such as Single Molecule Real Time (SMRT) and Nanopore, are gaining traction due to their ability to accurately analyze complex genomic regions and detect large structural abnormalities that traditional methods often miss. These advantages allow for more efficient diagnostics, particularly for genetic disorders. Additionally, increased investments from major companies are expected to propel market growth, as seen in partnerships aimed at developing advanced genomic technologies for drug development and companion diagnostics.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Long Read Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Long Read Sequencing Market Segmental Analysis
Global Long Read Sequencing Market is segmented by Offerings, Technology, Workflow, Application, Usage, End Users and region. Based on Offerings, the market is segmented into Consumables, Instruments and Services. Based on Technology, the market is segmented into Nanopore sequencing, Single-molecule real-time sequencing and Synthetic long-read sequencing. Based on Workflow, the market is segmented into Sequencing, Sample Preparation and Data analysis. Based on Application, the market is segmented into Whole Genome Sequencing, Targeted Sequencing, Metagenomics, Epigenetics, Whole exome sequencing and Other applications. Based on Usage, the market is segmented into Research and Clinical. Based on End Users, the market is segmented into Academic & Research Institutes, Hospitals, Clinics & Diagnostic Labs, Pharmaceutical & Biotechnology Companies and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Long Read Sequencing Market
The Global Long Read Sequencing market is significantly propelled by the growing adoption of next-generation sequencing (NGS) technologies across diverse research domains such as genomics, transcriptomics, and epigenomics. These advanced sequencing methods enable researchers to obtain deeper insights into critical areas like genome assembly, gene expression, and DNA modification patterns. By enhancing the accuracy and completeness of genomic data, long read sequencing becomes an essential tool in NGS-based studies, further driving its implementation in various scientific investigations. This increasing demand for comprehensive genomic analysis fosters the overall growth of the long read sequencing market on a global scale.
Restraints in the Global Long Read Sequencing Market
The global Long Read Sequencing market faces several restraints, notably the high expenses associated with these advanced technologies. Compared to conventional short read sequencing, long read sequencing incurs greater costs related to equipment, reagents, and data analysis. This financial burden can restrict the implementation of long read sequencing methods, particularly in clinical diagnostics and resource-limited research environments, where budget constraints may hinder the widespread adoption of these innovative yet expensive sequencing options. Consequently, the elevated costs present a significant challenge for the growth and accessibility of long read sequencing in various sectors.
Market Trends of the Global Long Read Sequencing Market
The Global Long Read Sequencing market is witnessing robust growth as healthcare and research institutions increasingly adopt these advanced technologies for their superior ability to deliver comprehensive genomic insights. This shift is primarily fueled by the need for accurate genome assembly, structural variant analysis, and complex transcriptomic studies, which short read sequencing often struggles to address. Moreover, the expanding applications in personalized medicine, oncology, and genetic research are amplifying market demand, while technological advancements and reduced costs further enhance accessibility. As a result, long read sequencing is positioning itself as a pivotal tool in the genomics landscape, shaping the future of precision medicine and genetic research.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Global Long Read Sequencing Market Size by Offerings & CAGR (2025-2032)
Market Overview
Consumables
Instruments
Services
Global Long Read Sequencing Market Size by Technology & CAGR (2025-2032)
Market Overview
Nanopore sequencing
Single-molecule real-time sequencing
Synthetic long-read sequencing
Global Long Read Sequencing Market Size by Workflow & CAGR (2025-2032)
Market Overview
Sequencing
Sample Preparation
Data analysis
Global Long Read Sequencing Market Size by Application & CAGR (2025-2032)
Market Overview
Whole Genome Sequencing
Targeted Sequencing
Metagenomics
Epigenetics
Whole exome sequencing
Other applications
Global Long Read Sequencing Market Size by Usage & CAGR (2025-2032)
Market Overview
Research
Clinical
Global Long Read Sequencing Market Size by End Users & CAGR (2025-2032)
Market Overview
Academic & Research Institutes
Hospitals, Clinics & Diagnostic Labs
Pharmaceutical & Biotechnology Companies
Other End Users
Global Long Read Sequencing Market Size & CAGR (2025-2032)
North America (Offerings, Technology, Workflow, Application, Usage, End Users)
US
Canada
Europe (Offerings, Technology, Workflow, Application, Usage, End Users)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Offerings, Technology, Workflow, Application, Usage, End Users)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Offerings, Technology, Workflow, Application, Usage, End Users)
Brazil
Rest of Latin America
Middle East & Africa (Offerings, Technology, Workflow, Application, Usage, End Users)
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Intelligence
Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
Company Details
Product Portfolio Analysis
Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
Pacific Biosciences of California, Inc. (PacBio) (United States)
